Nevro Corp Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Nevro Corp Stock Summary

Nevro Corp competes with Integer Holdings, Glaukos Corp, CONMED, Pulmonx Corp, and Iradimed. Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California. Nevro Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 945 people.

Nevro Corp Key Financial Ratios

Nevro Corp Key Balance Sheet Accounts

Nevro Corp Key Income Statement Accounts

Nevro Corp Key Cash Accounts

Nevro Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nevro Corp's current stock value. Our valuation model uses many indicators to compare Nevro Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nevro Corp competition to find correlations between indicators driving Nevro Corp's intrinsic value. More Info.Nevro Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Nevro Corp's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nevro Corp's earnings, one of the primary drivers of an investment's value.

Nevro Corp's Earnings Breakdown by Geography

Nevro Corp Systematic Risk

Today, most investors in Nevro Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nevro Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nevro Corp growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Nevro Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nevro Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nevro Corp based on widely used predictive technical indicators. In general, we focus on analyzing Nevro Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nevro Corp's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.